From The Microbe Discovery Project.
Dr. Lipkin, Director of the Center for Infection and Immunity (CII) at Columbia University’s Mailman School of Public Health, has responded to the National Institutes of Health’s (NIH) request for information (RFI). The NIH had requested input for research strategies for (ME/CFS).
This response in the letter below, articulates concisely and clearly, the overarching outline of what the CII have undertaken so far and their future aims. In 2011 CII, along with leading researchers and specialist clinicians developed a ‘Center for Solutions for ME/CFS’ team. Priority urgent research needs are addressed in this response and important elements of future development. Among these are a clinician training Masters-level program, a patient registry, a biobank and a clinical trials program. Dr. Lipkin states:
“Addressing the challenges of ME/CFS will require the insights and resources of the best and brightest of clinicians and investigators in the United States and abroad. We are optimistic that the field is poised for breakthroughs in understanding that will impact how we diagnose, treat and prevent ME/CFS.”
To read the rest of this story, click on the link below: